Department of Infectious Disease, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
mSphere. 2024 Feb 28;9(2):e0067323. doi: 10.1128/msphere.00673-23. Epub 2024 Jan 30.
produces various hemolysins regulated by the Agr-QS system, except β-hemolysin encoded by the gene . A classical laboratory strain RN4220 displays only the β-hemolysin phenotype. It was suspected that the 8A mutation at the end of its gene delayed the expressions of and , then failed to express α- and δ-hemolysins. However, gene expression was detected at the later culture time without α-hemolysin phenotype, the reason for such a phenotype has not been clearly understood. We created knockout and complementary mutants via homologous recombination in RN4220 and NRS049, two strains that normally produce β-hemolysin and carry mutation. We found interestingly that the presence or absence of α-hemolysin phenotype in such strains depended on the expression of β-hemolysin instead of mutations, which only inhibited δ-hemolysin expression. The hemolysis phenotype was verified by the Christie-Atkinson-Munch-Peterson (CAMP) test. Quantitative reverse transcription PCR was carried out to evaluate the relative gene expressions of , , and . The construction of mutants did not affect the mutation status. We demonstrate that the absence of α-hemolysin in RN4220 and NRS049 strains is attributed to their production of β-hemolysin instead of mutation. Our findings broaden the understanding of the molecular mechanisms that control hemolysin expression in that is crucial for the development of new therapeutic strategies to combat infections.
α-Hemolysin is a critical virulence factor in and its expression is largely controlled by the Agr-QS system. Nonetheless, the hemolysis phenotype and the regulation of the Agr-QS system in still hold many mysteries. Our study finds that it is the expression of β- hemolysin rather than the mutation that inhibits the function of the α-hemolysin in an important strain RN4220 and a clinical strain presents a similar phenotype, which clarifies the misunderstood hemolytic phenotype and mechanism of . Our findings highlight the interactions among different toxins and their biological roles, combined with QS system regulation, which is ultimately the true underlying cause of its virulence. This emphasizes the importance of considering the collaborative action of various factors in the infection process caused by this significant human pathogen.
产生各种由 Agr-QS 系统调节的溶血素,除了由基因编码的β-溶血素。经典的实验室菌株 RN4220 仅表现出β-溶血素表型。有人怀疑其基因末端的 8A 突变延迟了和的表达,然后未能表达α-和δ-溶血素。然而,在后期培养时检测到基因表达,但没有表现出α-溶血素表型,这种表型的原因尚不清楚。我们通过同源重组在 RN4220 和 NRS049 中创建了基因敲除和互补突变体,这两个菌株通常产生β-溶血素并携带基因突变。我们发现一个有趣的现象,即这些菌株中是否存在α-溶血素表型取决于β-溶血素的表达,而不是突变,突变仅抑制δ-溶血素的表达。溶血表型通过 Christie-Atkinson-Munch-Peterson(CAMP)试验进行验证。进行定量逆转录 PCR 以评估、和基因的相对表达。突变体的构建不影响突变状态。我们证明,RN4220 和 NRS049 菌株中缺乏α-溶血素是由于它们产生β-溶血素而不是突变。我们的发现拓宽了对控制溶血素表达的分子机制的理解,这对开发新的治疗策略来对抗感染至关重要。
α-溶血素是的关键毒力因子,其表达在很大程度上受 Agr-QS 系统的控制。尽管如此,在重要的菌株 RN4220 和临床菌株中,溶血表型和 Agr-QS 系统的调节仍然存在许多谜团。我们的研究发现,是β-溶血素的表达而不是突变抑制了α-溶血素在重要菌株 RN4220 中的功能,并且在临床菌株中表现出相似的表型,这阐明了被误解的溶血表型和机制。我们的发现强调了不同毒素之间的相互作用及其生物学作用,结合 QS 系统调节,这最终是其毒力的真正根本原因。这强调了在由这种重要的人类病原体引起的感染过程中考虑各种因素协同作用的重要性。